- 121
- 318 611
Syngene
India
Приєднався 26 лис 2015
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.
Syngene's more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2 Mn sq.ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including GSK, Zoetis and Merck KGaA.
For more details, visit www.syngeneintl.com or write to us at bdc@syngeneintl.com
Syngene's more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2 Mn sq.ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including GSK, Zoetis and Merck KGaA.
For more details, visit www.syngeneintl.com or write to us at bdc@syngeneintl.com
Syngene's Analytical Development Facility
Syngene’s Analytical Development team is a leader in method development, method validation, method transfer, and application of analytical expertise to ensure the delivery of quality drug products for early as well as late-phase drug development programs. The team has expertise in developing phase-appropriate methods, validation, and transfer of the methods for drug substance and drug product (solid, semisolid, solutions, simple and complex long-acting parenteral formulations). Our team analyzes small molecules (RSMs, intermediates, and APIs), semi-large molecules (polymers, oligonucleotides), and biologics using a variety of spectroscopic, chromatographic, and physiochemical techniques.
Syngene also offers nitrosamine risk assessment and conformity testing services through its Nitrosamine impurity testing - center of excellence in compliance with regulatory guidelines.
Our expertise plays a vital role in supporting clients in the discovery and development processes of pharmaceuticals, fine chemicals, agrochemicals, and oligonucleotides. We ensure a high quality of service by monitoring key performance indicators or key quality indicators (KPIs/KQIs) that are defined at the beginning of the collaboration.
Syngene also offers nitrosamine risk assessment and conformity testing services through its Nitrosamine impurity testing - center of excellence in compliance with regulatory guidelines.
Our expertise plays a vital role in supporting clients in the discovery and development processes of pharmaceuticals, fine chemicals, agrochemicals, and oligonucleotides. We ensure a high quality of service by monitoring key performance indicators or key quality indicators (KPIs/KQIs) that are defined at the beginning of the collaboration.
Переглядів: 201
Відео
ED and CFO Sibaji Biswas on US Biosecure Act and its impact on Indian pharma companies
Переглядів 2963 місяці тому
Watch our ED and CFO, Sibaji Biswas, discuss Syngene's growth prospects and the evolving landscape in the CRDMO space on CNBC TV18's Half Time Report with Ekta Batra. During the discussion, Sibaji highlighted India's readiness to seize new opportunities, driven by its talent, scalable infrastructure, and available capital. Vishal Manchanda, pharma analyst from Systematix, also expressed strong ...
Syngene 31th Annual General Meeting - July 24, 2024
Переглядів 1493 місяці тому
Syngene 31th Annual General Meeting - July 24, 2024
Syngene's MD and CEO, Jonathan Hunt, on Q4 and FY24 results
Переглядів 2207 місяців тому
Watch now! Our MD and CEO, Jonathan Hunt, shares his perspective about the Q4 and FY24 performances along with the outlook for FY25. Highlights include - ◉ Improvement in biotech funding and positive indicators in the market ◉ Commissioning of new DMPK and QC Biologics labs expanded the scope of AI applications ◉ Positive market trends are expected to fuel growth Visit our website to learn more...
Syngene's CFO and Executive Director, Sibaji Biswas, on Q4 and FY24 results
Переглядів 1577 місяців тому
Tune in to our CFO and Executive Director, Sibaji Biwas, discussing Q4FY24 and full year performance, along with insights into FY25. He spoke about - ◉ Syngene strategically balancing CRO and CDMO segments to meet evolving client demands and ◉ Leveraging AI and data driven sciences to enhance the prospects of successful drug development Explore more about Syngene and our services on our website...
Operational Excellence Expo FY 24
Переглядів 2748 місяців тому
At Syngene, Operational Excellence is the shared responsibility of all employees. Our constant endeavor is to optimize and streamline processes and drive efficiency across the organization. To reflect on our journey towards Operational Excellence over the past year, we hosted the Operational Excellence Expo FY 24 earlier this month. The expo showcased more than 150 completed Lean Six Sigma proj...
Syngene's Small Molecule non-GMP Facility
Переглядів 3518 місяців тому
Syngene's non-GMP Manufacturing facility supports various chemical development offerings related to pharmaceuticals, cosmetics, and performance chemical industries. Integrated with Syngene’s supply chain comprising 2900 suppliers across 30 countries, the plant ensures faster and more secure supplies for our customers at competitive prices across a wide range of products at all times. -For more ...
Syngene Corporate Video 2024
Переглядів 3,3 тис.8 місяців тому
Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time...
Syngene's API Mangalore Manufacturing Plant- MSEZ #API #GMP #usfda
Переглядів 1,1 тис.9 місяців тому
Enabling quality-driven large-scale API manufacturing. State-of-the-art multi-product, multi-client contract manufacturing facility located at Mangalore Special Economic Zone (MSEZ) spread across a sprawling 46 acres campus. Plant designed to support large-scale API and advanced intermediate manufacturing. Offers large scale manufacturing capability in the range of 2 KL to 12.5 KL compliant wit...
Syngene's High Potent API Manufacturing facility
Переглядів 4689 місяців тому
Ensuring the safety, containment, analysis and production of potent compounds at every stage, from development to commercialization This facility has been meticulously designed to adeptly handle cytotoxic and cytostatic high-potency compounds, demonstrating a commitment to safety with an occupational exposure limit (OEL) of up to 0.01 µg/m, over an 8-hour period, categorizing it within Band 4/5...
State-of-the-art Quality Control Biologics Lab | Syngene
Переглядів 2,5 тис.9 місяців тому
Here’s a sneak peek of our new Quality Control Biologics lab! We take you on a virtual tour of our state-of-the-art facility that houses the latest technology and equipment for testing biologics products, with a strong focus on digitalization and automation. We also highlight our stringent quality control procedures and standards that are in place to ensure the accuracy and reliability of our r...
Syngene’s growth story: CRO to global CRDMO in 30 years
Переглядів 1 тис.10 місяців тому
Watch this captivating video showcasing Syngene's remarkable growth story from a contract research organization offering early-stage biology and chemistry research services to a leading, integrated contract research development and manufacturing partner to global clients.
Small Molecule cGMP Manufacturing Facility at Bangalore | Syngene
Переглядів 47210 місяців тому
Syngene offers flexible manufacturing solutions for small molecules. Our capabilities allow us to scale up manufacturing from laboratory volumes to commercial levels seamlessly. Syngene’s dedicated state-of-the-art cGMP manufacturing facilities (USFDA and PMDA approved) supports the small molecules contract manufacturing business. Since inception, we have successfully supplied clinical (early &...
End-to-end Oligonucleotides services: Early Discovery to cGMP Manufacturing | Syngene
Переглядів 23410 місяців тому
End-to-end Oligonucleotides services: Early Discovery to cGMP Manufacturing | Syngene
Celebrating our ‘long service heroes’ on our 30th anniversary: The heart of our company | Part 2
Переглядів 13510 місяців тому
Celebrating our ‘long service heroes’ on our 30th anniversary: The heart of our company | Part 2
Celebrating our ‘long service heroes’ on our 30th anniversary: The heart of our company | Part 1
Переглядів 31910 місяців тому
Celebrating our ‘long service heroes’ on our 30th anniversary: The heart of our company | Part 1
Syngene: Your partner in building a healthier world
Переглядів 67811 місяців тому
Syngene: Your partner in building a healthier world
How Syngene supports women in science #womeninscienceday #WomenInSTEM #csr
Переглядів 38911 місяців тому
How Syngene supports women in science #womeninscienceday #WomenInSTEM #csr
Empowering communities through healthcare and education
Переглядів 654Рік тому
Empowering communities through healthcare and education
Sibaji Biswas - Our CFO on Q2FY24 & First-half FY24 results #syngene #financialresults
Переглядів 434Рік тому
Sibaji Biswas - Our CFO on Q2FY24 & First-half FY24 results #syngene #financialresults
Jonathan Hunt - MD & CEO on Q2FY24 & First-half FY24 results #syngene #financialresults
Переглядів 243Рік тому
Jonathan Hunt - MD & CEO on Q2FY24 & First-half FY24 results #syngene #financialresults
Ensure regulatory-grade Safety profile of your lead compound | In Vitro & Genetic Toxicology #shorts
Переглядів 160Рік тому
Ensure regulatory-grade Safety profile of your lead compound | In Vitro & Genetic Toxicology #shorts
Full-stack In vitro & Genetic Toxicology services | Screening to IND submission
Переглядів 101 тис.Рік тому
Full-stack In vitro & Genetic Toxicology services | Screening to IND submission
Groundbreaking Ceremony in Genome Valley, Hyderabad 2023
Переглядів 420Рік тому
Groundbreaking Ceremony in Genome Valley, Hyderabad 2023
Syngene 30th Annual General Meeting- July 26, 2023
Переглядів 401Рік тому
Syngene 30th Annual General Meeting- July 26, 2023
Syngene Annual Report 2023: Exceptional Partnerships, Dynamic Growth
Переглядів 347Рік тому
Syngene Annual Report 2023: Exceptional Partnerships, Dynamic Growth
Meet us at BIO 2023 - Booth no: 265, Hall A
Переглядів 192Рік тому
Meet us at BIO 2023 - Booth no: 265, Hall A
World Environment Day - Message from our COO Dr. Mahesh Bhagat
Переглядів 189Рік тому
World Environment Day - Message from our COO Dr. Mahesh Bhagat
Dear Dr. Ramesh sir, This presentation is highly important who is going to work in Oligonucleotide. The way you explained about Oligonucleotide process development, Stage :- synthesis Detritylation, Coupling, Oxidation/sulphurisation,Capping, how to decide the solid support for Oligosynthesizer. Design of Experiment, what are the factors will play a critical role at the time of Oligosynthesizer. Stage :- Cleavage & deprotection, How to get separate Crude oligonucleotide from the solid support, what parameter will impact on this process. Temperature & time will play Avery crucial role in this reaction you explained very well. Stage :- Purification Mobile phase for the separation of the oligonucleotide, what will be the impurities may generate like N-1,N-2,N-X & PS-PO. How to separate these impurities at the time of ion exchange purification. Which technique can be used for analysis as this all molecules are having high molecular weight. Fraction pooling for next stage as main pool solution. Stage :- Ultrafiltration, How to do the exchange of ions to control the sodium during this stage Stage :- Lyophilization Finally lyophilized power & its complete analysis requirement. Thanks a lot for a sharing such a very good knowledge on future technology.
Yuvraj sir❤
Syngene💊⛑️ 🥼🧪🥽🧫🔬👩🏭👨🏭 Strengths: - Clearly communicates facility capabilities, supporting chemical development offerings across industries. - Highlights integrated supply chain for faster and secure supplies. - Emphasizes competitive pricing across a broad product range. Areas for Improvement: - Specify facility location for customer clarity. - Mention certifications or quality control measures to enhance customer confidence. - Consider including specific examples of chemical development offerings for target audience clarity.
Alla guru....ivregella bari brt....k.gudi Matra tribes iroda camarajanagara district Alli yeshtondhu tribal haadi galu idave alligella yaar hogi health checkup maadtare....???
This is Game changer.
Thank you!
Great 👍
I request you to Please invest in Bangalore itself😢, we are having shortage of jobs. Hyderabad already created several jobs.
Read the full press release 👉 panbela.com/wp-content/uploads/2023/08/PBLA-SBP101-EP-Patent.pdf Read the case study 👉 cdn.syngeneintl.com/2022/01/22234245/How-Syngene-helped-Panbela-achieve-shorter-production-time-for-its-pancreatic-cancer-drug.pdf
👍👍
Heeeee Jana Sona akjon k dekhe bhalo lagche
Valo laglo sibajike dekhe T v te bolbe kobe sunbo
Kobe T v te bolte sunbo
Is this organic synthesis laboratory ?
A very detailed presentation Dr. Ramesh.. Awesome.
This lab is better than any IIT, IISER OR CSIR chemistry LAB.
Great work by Syngene 👏
Joy ho
In monday pls make share 700 rs
ask for 1000rs atleast, so he could have some room for bargaining and actually set price to 700rs. "be greedy when others are fearful" @Warren Buffet
Love it..Jai Hind..
nice video
Dream to work with you👍
👉 ≋p≋r≋o≋m≋o≋s≋m
fresher vaccancy are available in company sir
One of the best experience in Syngene international relationship with Ashwini Abhijith please interview with you
He seems to get motivated everywhere.. hahaha
Safety measures taken by syngene are planned and organised .one can work without fear. Great 👍
Sir if E GENE SHOWING not detected and Results showing invalid what are the reasons behind that
It's my dream company. I'm applying from a long time to get a opportunity to work here .
You did what course in ug? Bsc or btech ?
It's my dream company..
Great👍
dynamic leader
My friend working in syngene
Personal hygiene not their ?
use the headcap, gloves in our area
Sameer sir
Very informative and helpful lecture
Nice demonstration.
Nice presentation....
Very good video on sample shipment management
informative session on handling bioanalytical sample shipments
Nice presentation about sampling and planning the shipping of bio-analytical samples across the different locations. Good work by Syngene.
Excellent video from syngene regarding Bio analytical samples shipment and management process flow.
Very nice presentation on sample handling system
Highly informative video on the sample handling procedures. Appreciate that.
Excellent work of syngene
Excellent lecture. Thank you.